在真菌菌菌病中的皮肤导向疗法:最新情况
Maciej Tota1, Magdalena Łyko2, Piotr Misiąg3
1Faculty of Medicine, Wroclaw Medical University, Pasteura 1, 50-367, Wroclaw, Poland. maciej.tota@student.umw.edu.pl.
Dermatology and therapy
|August 14, 2025
概括
肌肉T细胞淋巴瘤的一种类型 - - 菌性菌 (MF) - - 用皮肤导向疗法 (SDT) 进行治疗. 本综述详细介绍了MF的既定和新兴SDT,重点关注有效性和安全性.
科学领域:
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
- 皮肤淋巴瘤研究研究
背景情况:
- 菌根性菌症 (MF) 是最常见的皮肤T细胞淋巴瘤 (CTCL).
- 早期的多发性肺炎管理优先考虑皮肤导向疗法 (SDTs) 以控制疾病和改善生活质量 (QoL).
研究的目的:
- 提供针对真菌菌菌病 (MF) 的皮肤导向疗法 (SDT) 的最新审查.
- 总结既定和新兴SDT的指示,机制,有效性和不良影响.
- 要突出正在进行的临床试验,用于新型SDTs在MF治疗.
主要方法:
- 对MF的皮肤导向疗法的综合文献综述.
- 分析已建立的治疗方法,包括局部药物 (皮质类固醇,视网类固醇,甲甲胺,卡慕斯,伊米基莫德),光动力疗法 (PDT),光疗法 (nb-UVB,PUVA) 和放射疗法 (局部,TSEBT,TSHT).
- 包括新兴SDT正在进行的临床试验的数据.
主要成果:
- 在MF治疗中使用的各种局部药物,光疗和放射疗法的详细疗效和安全性概况.
- 识别MF不同阶段的已建立的SDT.
- 目前正在临床试验中进行调查的新兴SDT的概述.
结论:
- 针对皮肤的疗法 (SDT) 对于管理真菌菌菌病 (MF) 至关重要,可提供疾病控制和缓解症状.
- 有一系列既定和新型SDT可用,每个都有特定的指示,疗效和副作用概况.
- 目前正在进行的研究和临床试验继续扩大MF治疗的治疗领域.
相关概念视频
Skin Cancer
4.5K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.5K
Skin Diseases and Disorders
4.1K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.1K
Changes in Skin Color: Clinical Perspectives
2.2K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
2.2K
Renewal of Skin Epidermal Stem Cells
2.6K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.6K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
271
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
271
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


